Hospitals reduced central line-associated bloodstream infections by 50% between 2008 and 2016, according to a new progress summary by the Centers for Disease Control and Prevention. The report also shows progress by hospitals in reducing other healthcare-associated infections, including catheter-associated urinary tract, surgical site, methicillin-resistant staphylococcus aureus and Clostridium difficile infections. The AHA’s Health Research & Educational Trust affiliate has been working with the CDC to reduce CLABSI, CAUTI, C difficile and MRSA infections in targeted acute care hospitals. HRET also has worked with the Agency for Healthcare Research and Quality’s Comprehensive Unit Based Safety Program to prevent CLABSI and CAUTI infections, and with the Centers for Medicare & Medicaid Services’ Hospital Improvement Innovation Networks to continue to reduce hospital-acquired conditions in the Medicare program.

Related News Articles

Headline
The AHA July 19 expressed concerns to the Department of Labor about the Occupational Safety and Health Administration’s proposed emergency response rule. The…
Headline
Boston Medical Center, a private, not-for-profit, equity-led academic medical center, is the winner of AHA’s 2024 Foster G. McGaw Prize for its leadership and…
Headline
WellSpan Health in York, Pa., will receive the 2024 AHA Quest for Quality Prize for its commitment to improving quality through its health equity strategic…
Headline
Access to quality mental and physical health services can be a complex challenge, but for individuals of color and people with severe or chronic mental…
Blog
ESPAÑOLWhat if one conversation can change, or even save, a life? That was the question AdventHealth sought to answer, as the health system launched a…
Headline
Antimicrobial-resistant infections remained above pre-pandemic levels in 2022, the Centers for Disease Control and Prevention reported July 16. CDC data show…